Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 248 clinical trials
A Study on the Phenomenon of Remote Ischaemic Preconditioning in Patients With Peripheral Artery Disease

This study aims to evaluate whether remote ischemic preconditioning (RIPC) daily for 28 days reduces the symptoms of intermittent claudication in patients with peripheral artery disease (PAD

  • 08 Jun, 2022
  • 1 location
Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease

The purpose of this study is to understand how a Best Practice Advisory (BPA) for high-intensity statin therapy in patients with Peripheral Artery Disease impacts prescription rates.

  • 25 May, 2022
  • 1 location
Moderate Intensity Functional Training as Adjuvant Treatment in Patients With Peripheral Arterial Disease

peripheral arterial disease (PAD). However, the transfer of the current resistance exercise modes proposed to other activities of daily living (ADLs) is questionable. Moderate intensity functional training

  • 26 Nov, 2021
  • 1 location
Arm-crank Exercise Training on Cardiovascular Function of Patients With Peripheral Artery Disease

The aim of the study is to analyze the effect of 12 weeks of arm crank exercise (ACE) training on cardiovascular function in PAD patients, and compare it with treadmill exercise (TE), the actual recommendation for this patients. In this clinical trial, 45 patients will be allocated randomly in three …

peripheral arterial diseases
peripheral artery disease
health impairment
  • 14 Feb, 2022
  • 1 location
Compare the Efficacy and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease

The purpose of this clinical trial is to demonstrate the non-inferiority of GENOSS DCB versus IN.PACT Admiral DCB on late lumen loss 6 months after the procedure in patients with de novo or non-stented restenotic lesions of the superficial femoral artery and popliteal artery and to evaluate the safety. This …

  • 23 Mar, 2022
  • 1 location
VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.

Peripheral Arterial Disease (PAD) is a highly debilitating disease that affects 202 million people around the world and about 7 million people in France. Morbi-mortality from cardiovascular

  • 13 Dec, 2021
  • 2 locations
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

The purpose of this study is to understand how the drug rivaroxaban improves symptoms associated with peripheral artery disease.

  • 30 Apr, 2022
  • 1 location
ACOART BTK RENEW:A Post Market Clinical Study

The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Acotec Litos&Tulip Drug-coated Balloon catheters in the treatment of lesions in below-the-knee artery.

  • 11 Apr, 2022
Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease (LIMES)

This study is a prospective, interventional, multicenter 1:1 randomized trial. The trial evaluates the safety and efficacy of the Magic Touch PTA sirolimus drug-coated balloon in comparison to the treatment with POBA (control device) in patients with infrapopliteal artery disease.

  • 24 Apr, 2022
  • 8 locations

Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement

  • 26 Oct, 2021
  • 1 location